Cargando…
'Rac'-ing upstream to treat rheumatoid arthritis
Signal transduction pathways regulate the production and function of many cytokines implicated in immune-mediated diseases. Targeting these enzymes with small molecule inhibitors represents a fertile field for the treatment of rheumatoid arthritis. Recent successes with compounds that block upstream...
Autor principal: | Firestein, Gary S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875651/ https://www.ncbi.nlm.nih.gov/pubmed/20236447 http://dx.doi.org/10.1186/ar2924 |
Ejemplares similares
-
The disease formerly known as rheumatoid arthritis
por: Firestein, Gary S
Publicado: (2014) -
Pathogenesis of rheumatoid arthritis: how early is early?
por: Firestein, Gary S
Publicado: (2005) -
Rac-ing to the plasma membrane: The long and complex work commute of Rac1 during cell signaling
por: Bustelo, Xosé R., et al.
Publicado: (2012) -
Innate Immunity as a Hired Gun: But Is It Rheumatoid Arthritis?
por: Corr, Maripat, et al.
Publicado: (2002) -
Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)